These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Reglodi D; Kiss P; Lubics A; Tamas A Curr Pharm Des; 2011; 17(10):962-72. PubMed ID: 21524257 [TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Vaudry D; Rousselle C; Basille M; Falluel-Morel A; Pamantung TF; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6398-403. PubMed ID: 11972030 [TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Vaudry D; Gonzalez BJ; Basille M; Pamantung TF; Fontaine M; Fournier A; Vaudry H Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13390-5. PubMed ID: 11087878 [TBL] [Abstract][Full Text] [Related]
7. [Neuroprotective role of PACAP, VIP, and PHI in the central nervous system]. Sokołowska P; Dejda A; Nowak JZ Postepy Hig Med Dosw (Online); 2004; 58():416-27. PubMed ID: 15577749 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of PACAP in ischemia. Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688 [TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562 [TBL] [Abstract][Full Text] [Related]
10. PACAP as a neuroprotective factor in ischemic neuronal injuries. Shioda S; Nakamachi T Peptides; 2015 Oct; 72():202-7. PubMed ID: 26275482 [TBL] [Abstract][Full Text] [Related]
11. PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP. Mei YA; Vaudry D; Basille M; Castel H; Fournier A; Vaudry H; Gonzalez BJ Eur J Neurosci; 2004 Mar; 19(6):1446-58. PubMed ID: 15066141 [TBL] [Abstract][Full Text] [Related]
12. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. Falluel-Morel A; Aubert N; Vaudry D; Basille M; Fontaine M; Fournier A; Vaudry H; Gonzalez BJ J Neurochem; 2004 Dec; 91(5):1231-43. PubMed ID: 15569266 [TBL] [Abstract][Full Text] [Related]
13. Pituitary Adenylyl Cyclase Activating Polypeptide (PACAP) Signaling and the Cell Cycle Machinery in Neurodegenerative Diseases. Polanco MJ; Pennuto M Curr Pharm Des; 2018; 24(33):3878-3891. PubMed ID: 30479210 [TBL] [Abstract][Full Text] [Related]
14. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1. Yu R; Zheng L; Cui Y; Zhang H; Ye H Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of PACAP for neurodegenerative diseases. Yang R; Jiang X; Ji R; Meng L; Liu F; Chen X; Xin Y Cell Mol Biol Lett; 2015 Jun; 20(2):265-78. PubMed ID: 26204407 [TBL] [Abstract][Full Text] [Related]
16. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905 [TBL] [Abstract][Full Text] [Related]